Company page

Grifols, S.a. Class A

Grifols, S.A. Class A is a publicly traded company based in Spain, with a market capitalization of approximately €6.25 billion. The company specializes in the production of plasma-derived medicines and operates in the healthcare sector. Grifols is committed to improving the quality of life for patients worldwide through innovative therapies and solutions.